NCT02906514View on ClinicalTrials.gov

Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Extracorporeal CirculationCardiac Surgery
Interventions
DRUG

Non balanced Hydroxyethyl starch 130/0.4 (Voluven®, Fresenius)

1000mL used for cardiopulmonary bypass priming

DRUG

Sodium Chloride 0.9% (Fresenius)

1000mL used for cardiopulmonary bypass priming

Trial Locations (1)

69500

Hospices Civils de Lyon - Hopital Louis Pradel, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02906514 - Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery | Biotech Hunter | Biotech Hunter